INVO FERTILITY INC (IVF) Stock Price, Quote, News and Overview
NASDAQ:IVF - Nasdaq - US44984F6097 - Common Stock - Currency: USD
IVF Quote, Performance and Key Statistics
1.46
-0.03 (-2.01%)
The current stock price of IVF is 1.46 USD. In the past month the price decreased by -32.41%.
IVF Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.95 | 232.41B | ||
| ISRG | INTUITIVE SURGICAL INC | 72.92 | 199.67B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.81 | 151.04B | ||
| SYK | STRYKER CORP | 30.64 | 146.71B | ||
| MDT | MEDTRONIC PLC | 15.9 | 112.15B | ||
| BDX | BECTON DICKINSON AND CO | 12.31 | 49.71B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.82 | 45.47B | ||
| IDXX | IDEXX LABORATORIES INC | 46.04 | 42.54B | ||
| RMD | RESMED INC | 27.78 | 36.98B | ||
| DXCM | DEXCOM INC | 52.53 | 33.98B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.57 | 32.79B | ||
| STE | STERIS PLC | 26.09 | 23.95B |
Related stock screener links
About IVF
Company Profile
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Company Info
INVO FERTILITY INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 25
Phone: 19788789505
INVO FERTILITY INC / IVF FAQ
What is the stock price of INVO FERTILITY INC today?
The current stock price of IVF is 1.46 USD. The price decreased by -2.01% in the last trading session.
What is the ticker symbol for INVO FERTILITY INC stock?
The exchange symbol of INVO FERTILITY INC is IVF and it is listed on the Nasdaq exchange.
On which exchange is IVF stock listed?
IVF stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INVO FERTILITY INC stock?
5 analysts have analysed IVF and the average price target is 6.12 USD. This implies a price increase of 319.18% is expected in the next year compared to the current price of 1.46. Check the INVO FERTILITY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INVO FERTILITY INC worth?
INVO FERTILITY INC (IVF) has a market capitalization of 3.14M USD. This makes IVF a Nano Cap stock.
How many employees does INVO FERTILITY INC have?
INVO FERTILITY INC (IVF) currently has 25 employees.
Is INVO FERTILITY INC (IVF) expected to grow?
The Revenue of INVO FERTILITY INC (IVF) is expected to grow by 10.02% in the next year. Check the estimates tab for more information on the IVF EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INVO FERTILITY INC (IVF) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IVF, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IVF, evaluating the profitability, health, valuation and growth aspects
- INVO FERTILITY INC (IVF) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INVO FERTILITY INC (IVF) Sales and EPS estimates to see what analysts future expectations are.
- INVO FERTILITY INC (IVF) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INVO FERTILITY INC (IVF) Insider and Institutional Ownership to learn about the owners and their transactions.
- INVO FERTILITY INC (IVF) Stock Chart to make your own analysis
- INVO FERTILITY INC (IVF) Latest news and press-releases to stay up to date.
Does INVO FERTILITY INC (IVF) stock pay dividends?
IVF does not pay a dividend.
When does INVO FERTILITY INC (IVF) report earnings?
INVO FERTILITY INC (IVF) will report earnings on 2025-08-12.
What is the Price/Earnings (PE) ratio of INVO FERTILITY INC (IVF)?
INVO FERTILITY INC (IVF) does not have a PE ratio as the earnings reported over the last twelve months were negative (-23.21).
What is the Short Interest ratio of INVO FERTILITY INC (IVF) stock?
The outstanding short interest for INVO FERTILITY INC (IVF) is 1.33% of its float. Check the ownership tab for more information on the IVF short interest.
IVF Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to IVF.
IVF Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IVF. Both the profitability and financial health of IVF have multiple concerns.
IVF Financial Highlights
Over the last trailing twelve months IVF reported a non-GAAP Earnings per Share(EPS) of -23.21. The EPS decreased by -309.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.24% | ||
| ROE | -343.9% | ||
| Debt/Equity | 0.27 |
IVF Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to IVF. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 92.84% and a revenue growth 10.02% for IVF